Frontier Biotechnologies Inc. (SHA:688221)

Frontier Biotechnologies Statistics

Total Valuation

SHA:688221 has a market cap or net worth of CNY 7.90 billion. The enterprise value is 7.65 billion.

Market Cap	7.90B
Enterprise Value	7.65B

Important Dates

The last earnings date was Tuesday, March 31, 2026.

Earnings Date	Mar 31, 2026
Ex-Dividend Date	n/a

Share Statistics

SHA:688221 has 374.58 million shares outstanding. The number of shares has increased by 0.42% in one year.

Current Share Class	374.58M
Shares Outstanding	374.58M
Shares Change (YoY)	+0.42%
Shares Change (QoQ)	-0.39%
Owned by Insiders (%)	16.08%
Owned by Institutions (%)	6.77%
Float	211.94M

Valuation Ratios

The trailing PE ratio is 2,282.80 and the forward PE ratio is 878.18.

PE Ratio	2,282.80
Forward PE	878.18
PS Ratio	20.15
PB Ratio	7.13
P/TBV Ratio	8.02
P/FCF Ratio	312.71
P/OCF Ratio	197.78
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 99.27, with an EV/FCF ratio of 302.50.

EV / Earnings	2,208.24
EV / Sales	19.49
EV / EBITDA	99.27
EV / EBIT	267.55
EV / FCF	302.50

Financial Position

The company has a current ratio of 3.54, with a Debt / Equity ratio of 0.43.

Current Ratio	3.54
Quick Ratio	2.49
Debt / Equity	0.43
Debt / EBITDA	6.12
Debt / FCF	18.66
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is 0.31% and return on invested capital (ROIC) is 1.17%.

Return on Equity (ROE)	0.31%
Return on Assets (ROA)	1.00%
Return on Invested Capital (ROIC)	1.17%
Return on Capital Employed (ROCE)	1.92%
Weighted Average Cost of Capital (WACC)	9.51%
Revenue Per Employee	1.30M
Profits Per Employee	11,464
Employee Count	524
Asset Turnover	0.22
Inventory Turnover	1.31

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +147.07% in the last 52 weeks. The beta is 1.06, so SHA:688221's price volatility has been similar to the market average.

Beta (5Y)	1.06
52-Week Price Change	+147.07%
50-Day Moving Average	20.18
200-Day Moving Average	19.09
Relative Strength Index (RSI)	54.66
Average Volume (20 Days)	19,443,311

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, SHA:688221 had revenue of CNY 392.19 million and earned 3.46 million in profits. Earnings per share was 0.01.

Revenue	392.19M
Gross Profit	311.11M
Operating Income	28.58M
Pretax Income	3.46M
Net Income	3.46M
EBITDA	76.33M
EBIT	28.58M
Earnings Per Share (EPS)	0.01

Balance Sheet

The company has 729.72 million in cash and 471.59 million in debt, with a net cash position of 258.13 million or 0.69 per share.

Cash & Cash Equivalents	729.72M
Total Debt	471.59M
Net Cash	258.13M
Net Cash Per Share	0.69
Equity (Book Value)	1.11B
Book Value Per Share	2.97
Working Capital	924.04M

Cash Flow

In the last 12 months, operating cash flow was 39.96 million and capital expenditures -14.69 million, giving a free cash flow of 25.27 million.

Operating Cash Flow	39.96M
Capital Expenditures	-14.69M
Depreciation & Amortization	47.75M
Net Borrowing	105.29M
Free Cash Flow	25.27M
FCF Per Share	0.07

Margins

Gross margin is 79.33%, with operating and profit margins of 7.29% and 0.88%.

Gross Margin	79.33%
Operating Margin	7.29%
Pretax Margin	0.88%
Profit Margin	0.88%
EBITDA Margin	19.46%
EBIT Margin	7.29%
FCF Margin	6.44%

Dividends & Yields

SHA:688221 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	223.76%
Buyback Yield	-0.42%
Shareholder Yield	-0.42%
Earnings Yield	0.04%
FCF Yield	0.32%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	7